|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Patento numeris | 2558592 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11717518.2 |
| Europos patento paraiškos padavimo data | 2011-04-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-02-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-10-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/055579 |
| Data | 2011-04-11 |
| (87) | Numeris | WO 2011/128278 |
| Data | 2011-10-20 |
| (30) | Numeris | Data | Šalis |
| 323502 P | 2010-04-13 | US |
| (72) |
CHU, Tom, US
ESSIOUX, Laurent, FR
GERMER, Soren, US
LOPATIN, Uri, US
SHULMAN, Nancy, US
THOMMES, James, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstra e 124, 4070 Basel,
CH
|
| (54) | SINGLE NUCLEOTIDE POLYMORPHISMS THAT PREDICT HCV TREATMENT OUTCOMES |
| SINGLE NUCLEOTIDE POLYMORPHISMS THAT PREDICT HCV TREATMENT OUTCOMES |